Sarepta Therapeutics, Inc. (SRPT) total debt

Total debt · fiscal 2025
$1.04B

Sarepta Therapeutics, Inc. (SRPT) carried total debt of $1.04B at the end of fiscal 2025 (December 31, 2025). That is 22.6% lower than the $1.34B of fiscal 2024. Figures as of 18 Nov 2026, 07:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$1.04B
Change on fiscal 2024
−22.6%
Growth, 10 years
+44.2% a year
Highest on record
$1.62Bfiscal 2022
Lowest on record
$1.67Mfiscal 2013
Fiscal years on record
142010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Sarepta Therapeutics, Inc. total debt, in more detail

Over the ten fiscal years to 2025 total debt grew at a compound 44.2% a year. Across the 14 fiscal years on record (2010–2025), the highest was $1.62B in fiscal 2022 and the lowest $1.67M in fiscal 2013.

Total debt was 0.9× shareholders' equity at the end of fiscal 2025.

History · 14 fiscal years

Total debt by fiscal year

Sarepta Therapeutics, Inc. total debt, year by year

Sarepta Therapeutics, Inc. (SRPT) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$1.04B 22.6% down0.9×
2024$1.34B 3.8% down0.9×
2023$1.40B 13.6% down1.6×
2022$1.62B 186.9% up4.2×
2021$563.67M—0.6×
2018$420.55M 2.4% down0.4×
2017$431.05M 2,339.7% up0.5×
2016$17.67M 34.2% down0.1×
2015$26.84M 278.1% up0.1×
2014$7.10M 325.5% up0.0×
2013$1.67M 5.1% down0.0×
2012$1.76M 4.6% down0.0×
2011$1.84M 4.2% down0.1×
2010$1.92M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on SRPT

Sarepta Therapeutics, Inc., figure by figure

Sarepta Therapeutics, Inc. (SRPT) overview: price, valuation and scorecard

Sarepta Therapeutics, Inc. total debt: questions and answers

How much debt does Sarepta Therapeutics, Inc. have?

Sarepta Therapeutics, Inc. (SRPT) carried total debt of $1.04B at the end of fiscal 2025 (December 31, 2025). That is 22.6% lower than the $1.34B of fiscal 2024.

What is the growth rate of Sarepta Therapeutics, Inc.'s total debt?

Over the ten fiscal years to 2025 total debt grew at a compound 44.2% a year.

What are the highest and lowest total debt figures on record for Sarepta Therapeutics, Inc.?

Across the 14 fiscal years on record (2010–2025), the highest was $1.62B in fiscal 2022 and the lowest $1.67M in fiscal 2013.

How does Sarepta Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.9× shareholders' equity at the end of fiscal 2025.

How is Sarepta Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sarepta Therapeutics, Inc. (SRPT) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/SRPT/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.